Kyowa Hakko Kirin Launches Allergy Tablet
This article was originally published in PharmAsia News
Executive Summary
Kyowa Hakko Kirin launched Nov. 25 oral disintegration tablet Allelock (olopatadine) for allergies
Kyowa Hakko Kirin launched Nov. 25 oral disintegration tablet Allelock (olopatadine) for allergies. The new formulation is targeting children over seven years and senior patients. The new tablet uses Kyowa proprietary Solblet and Exlub technologies which maintain the same hardness as normal tablets but rapidly dissolves the tablet when mixed with saliva. It also provides convenience to patients when taking the drug without water. (Click here for more - Japanese language) "Kyowa Hakko Kirin Launches Waterless Allergy Tablet" - Nikkei Sangyo News (11/26/2010) |